Price $6.50 |
Market Cap
91.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.59
|
P/S
2.18
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
33.4
|
Op. Cash Flow
3.1K
|
FCF
0.1
|
|
Op. Margin
-18.00%
|
Net Margin
-17.10%
|
ROE
-11.90%
|
ROI
-9.80%
|
|
ROA
-7.30%
|
EPS Growth
10.70%
|
Current Ratio
2.1
|
Debt/Equity
35.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| VIVUS, Inc. (VVUS) | $3.89 | - | - | 39M | Strong Buy |
| Infinity Pharmaceuticals Inc. (INFI) | $1.47 | - | - | 88.2M | Strong Buy |
| Horizon Pharma PLC (HZNP) | $25.83 | - | - | 4.67B | Strong Buy |
| Hologic, Inc. (HOLX) | $44.87 | - | - | 12.09B | Strong Buy |
| Milestone Scientific Inc. (MLSS) | $0.39 | - | - | 18.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
